Introduction
============

Retroperitoneal tumors (RTs) typically develop insidiously; they are generally found as large masses, and often 50% of RTs are larger than 20 cm at the time of diagnosis.^[@R1])^ Since most of them are malignant, surgery is indicated. Within the differential diagnosis of RTs, one of the most important are germ cell tumors (GCTs) derived from germ cells. These tumors present in patients between 15 and 35 years. Most GCTs are gonadal, and only 5% present as extra gonadal form.^[@R2])^ Teratomas are a frequent subtype of nonseminomatous germ cell tumors (NSGCTs), some of them have a malignant transformation, including: rhabdomyosarcoma, leiomyosarcoma or angiosarcoma,^[@R3])^ as the case we present, who has a mixed component.

Previous studies have favored inferior vena cava (IVC) reconstruction when resection is necessary for RT removal, with very low morbidity and mortality reported.^[@R4])^ In our center, these cases are managed by a team of vascular and urology surgeons. We present a case of a 20 cm RT resection with primary IVC reconstruction avoiding the use of prosthetic material while maintaining vessel patency.

Case Report
===========

A 30 year old male with no previous medical history noted a painless, abnormal growth on his right testicle in 2013. A whole body computed tomography (CT) scan completed at an outside hospital excluded metastases. A right radical orchiectomy was performed, and a teratoma was reported on histopathology. The previous surgery and initial follow-up was done in another institution. In 2016, he complained of abdominal pain, fever and weight loss. A CT scan revealed a retroperitoneal tumor of 75×80 mm, leading to 8 cycles of chemotherapy treatment in 2017 based on ifosfamide 1200 mg/m^2^, cysplatine 20 mg/m^2^ and vinblastine 0.11 mg/m^2^. The patient was referred to our institution in January 2018, presenting with an elevated alpha fetus protein (AFP) of 14,604.5 ng/mL. A CT scan revealed a right paramedial retroperitoneal tumor of 19×7.5 cm with involvement of the IVC and aorta. The tumor surrounded the right renal artery ([**Fig. 1**](#figure1){ref-type="fig"}). He received four cycles of etoposide 100 mg/m^2^, cysplatine 20 mg/m^2^ and bleomycin 30 U, with partial response measured, with AFP decreasing from 14,604.5 ng/mL to 125 ng/mL after the cycles. In April 2018, one month after the last dose of chemotherapy, a pulmonary thromboembolism and a thrombosis of the bilateral common, external, and internal iliac veins was documented, so rivaroxaban 20 mg per day was started. Lower limb edema and pain did not improve after a month with anticoagulation treatment.

![Fig. 1 (**a**) An axial view of the tumor constricting the right renal artery (yellow arrow), pushing the aorta (red arrow) and inferior vena cava (IVC; blue arrow). The tumor size was 19×17.5 cm; (**b**) Coronal view of the tumor deviating the aorta (red arrow), and the infrarenal IVC seen before it gets collapsed by the tumor (blue arrow).](avd-12-2-cr.18-00159-figure01){#figure1}

The case was discussed in the hospital, and surgical resection was agreed by the Urology and Vascular Surgery teams. The patient was placed in supine position, and surgery was performed through a vertical midline incision. After accessing the peritoneal cavity, we retracted the small intestine to the patient's left. The lateral peritoneal attachments of the right colon were incised concomitantly. The second and third portions of the duodenum were also mobilized by incising retroperitoneal attachments, retracting everything to the left. Retroperitoneal exposure was achieved, and the underlying IVC was dissected. The suprarenal and infra-renal portions of the IVC were encircled with a vascular tape. Finally, the left and right renal veins were controlled with vessel loops. A retro-caval tumor of 20 cm was identified; then IVC was divided a number 11 scalpel for adequate exposure of the tumor. After IVC transection, the tumor was resected. Finally the IVC was primarily end to end re-anastomosed with a prolene 6-0 suture without complications ([**Fig. 2**](#figure2){ref-type="fig"}). On histopathology, a mixed GCTs (70% teratoma with component of rhabdomyosarcoma and 30% of yolk sac tumor) was reported ([**Fig. 3**](#figure3){ref-type="fig"}). The patient was admitted to the intensive care unit for follow-up. His lower limb edema and pain diminished. He was discharged to the outpatient center unit two weeks later for follow-up.

![Fig. 2 A surgical bed after tumor resection.](avd-12-2-cr.18-00159-figure02){#figure2}

![Fig. 3 (**a**) A resected tumor measuring 10×9 cm; (**b**) 4× magnification, hematoxylin and eosin stain in which we observe hyalin cartilage that alternates with tissue of heterologous differentiation. (**c**) 100× magnification, immunohistochemistry which shows positivity in cytoplasm for desmin in cells with rhabdomyosarcoma differentiation.](avd-12-2-cr.18-00159-figure03){#figure3}

Discussion
==========

Resection of RT is challenging for surgeons because of their inaccessible location, their difficult exposure during surgery, and difficulty predicting their clinical behavior.

In patients with large tumors, pre-operative biopsy would not be recommended due to the risk of tumor spread during the biopsy procedure.^[@R1])^

The most common age of GCT presentation is between 15 and 35 years old, as was the case with our patient. To diagnose and provide a prognosis for GCTs, it is crucial to order testicular tumor markers; the most common are: AFP, β-human chorionic gonadotrophin, and lactate dehydrogenase. AFP is expressed by trophoblastic elements and yolk sac tumors.^[@R2])^ These tumor markers are important for evaluating response to treatment, such as elevation of testicular tumor markers following orchidectomy, which may indicate metastatic disease.^[@R2])^ Our patient had elevation of AFP five years after orchiectomy.

Patients with mixed GCT are treated like a NSGCTs. In more than 80% of patients with this kind of tumor, the primary metastatic site is the retroperitoneal nodes. It is also the most frequently involved site of chemoresistant mature teratoma, which holds the potential for malignant transformation.^[@R5])^ Although systemic chemotherapy is a potential curative treatment in patients with residual masses and elevated AFP, retroperitoneal lymph node dissection (RPLND) remains an important part of treating patients with NSGCTs in the United States of America. In NSGCTs, post-chemotherapy RPLND is indicated for patients with residual masses irrespective of size and normalization of tumor markers^[@R5])^; patients with teratomas and previous chemotherapy suffer malignant transformation more frequently due to resistance, and these recurrences must be treated with large resections.^[@R6],[@R7])^

The goal in surgical management of RTs is to achieve negative surgical borders because, in the presence of a positive surgical border, survival decreases significantly. These tumors involve the IVC and the abdominal aorta in 6--10% and 2%, respectively.^[@R5])^ The IVC is commonly compromised by partial or complete compression, wall invasion, and vessel encasing by the tumor.^[@R8])^ When the IVC is infiltrated, circumferential resection is necessary since two-thirds of the patients harbor vital cancer or mature teratoma in the infiltrating masses.^[@R5])^

The resection and primary reconstruction of the IVC is a procedure that is not widely mentioned in the literature. A trans-peritoneal exposure is often necessary to expose the infra-renal and peri-renal IVC.^[@R4])^ Most of the reports stated that IVC reconstruction is done with polytetrafluoroethylene (PTFE) due to better resistance to abdominal compression. Quinones-Baldrich and Farley^[@R4])^ recommend replacing the IVC with a ringed reinforced PTFE graft if there is no infection, arguing that the graft should be smaller than the diameter of the IVC (usually 12--14 mm) to get rapid flow and prevent graft thrombosis. In this case, we decided to perform a primary anastomosis, minimizing the risk of complications such as thrombosis, graft infection, graft erosion, and migration, which are particularly higher in oncologic patients due to immunosuppression.

During the procedure, patients tolerate IVC clamping most of the time. The only important consideration during unclamping is to place the patient in the Trendelenburg position with a Valsalva maneuver to avoid air embolism.^[@R4])^ Described, step-by-step techniques to reconstruct the IVC have been reported depending on the localization and percentage of IVC involvement. Some surgeons prefer to ligate the IVC because the procedure is well tolerated if collateral circulation is preserved during the tumor resection. However, there are reports indicating 50% of these patients will experience lower extremity edema, leading to venous gangrene if there are insufficient collateral vessels.^[@R4])^ Trying to avoid this postoperative venous hypertension, we favor IVC reconstruction, either with PTFE graft or primary repair. During follow-up, IVC reconstruction is not an absolute indication to anticoagulate. Postoperative anticoagulation is based on clinical indications. All patients having IVC reconstruction should receive aspirin for life.^[@R4])^

Conclusion
==========

It is important that RTs have a well established pre-operative plan, and they should be treated by an experienced team of surgeons.

Today, the only current treatment option that prolongs survival in patients with these tumors is wide surgical resection. This patient is an example, as described in the literature, that a primary IVC repair can be done safely, without intraoperative and postoperative complications, leading to a better prognosis for the patient.
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